ANRO — Alto Neuroscience, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2024-02-02.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ANRO
| date | signal | measured base rate |
|---|---|---|
| 2026-08-13 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
| 2026-08-07 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-08-06 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-07-14 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-07-01 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-06-29 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-05-14 | Etkin Amit PRESIDENT AND CEO | Gift | 400.0K | 0.00 | 0 |
| 2026-03-01 | Etkin Amit PRESIDENT AND CEO | Shares withheld for tax | 6.2K | 19.69 | 122.6K |
| 2026-03-01 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Shares withheld for tax | 2.8K | 19.69 | 55.3K |
| 2024-07-10 | Savitz Adam CHIEF MEDICAL OFFICER | Open-market purchase | 2.9K | 13.22 | 38.7K |
| 2024-07-09 | Savitz Adam CHIEF MEDICAL OFFICER | Open-market purchase | 10.7K | 12.53 | 133.8K |
| 2024-07-09 | Savitz Adam CHIEF MEDICAL OFFICER | Open-market purchase | 1.4K | 13.15 | 18.3K |
| 2024-03-28 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | Open-market purchase | 4.5K | 16.56 | 75.3K |
| 2024-03-28 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | Open-market purchase | 1.6K | 15.80 | 25.3K |
| 2024-03-01 | Etkin Amit PRESIDENT AND CEO | Grant or award | 34.7K | 0.00 | 0 |
| 2024-03-01 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | Grant or award | 19.2K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Alpha Wave Global, LP | 83.4M | 3.7M |
| Commodore Capital LP | 61.2M | 2.7M |
| Vestal Point Capital, LP | 46.4M | 2.1M |
| PERCEPTIVE ADVISORS LLC | 45.2M | 2.0M |
| Spruce Street Capital LP | 29.1M | 1.3M |
| VANGUARD CAPITAL MANAGEMENT LLC | 27.1M | 1.2M |
| FRANKLIN RESOURCES INC | 24.8M | 1.1M |
| Vivo Capital, LLC | 23.3M | 1.0M |
| ARMISTICE CAPITAL, LLC | 20.5M | 912.0K |
| MILLENNIUM MANAGEMENT LLC | 18.5M | 822.0K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Alto Neuroscience, Inc. (ANRO) filed form 8-K · 2026-08-12 · SEC EDGAR
Ask the AI about ANRO
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →